AP
Amplio Pharma develops novel drug delivery solutions to improve treatment efficacy for chronic autoimmune and immune-mediated inflammatory diseases. Utilizing proprietary NovoBioMed technology, the company effectively traps therapeutic agents within pro-inflammatory cells. This targeted approach aims to achieve faster disease remission with potentially lower overall drug dosages.
Updated 3 months ago
Funding
$820K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Amplio Pharma develops novel drug delivery solutions to improve treatment efficacy for chronic autoimmune and immune-mediated inflammatory diseases. Utilizing proprietary NovoBioMed technology, the company effectively traps therapeutic agents within pro-inflammatory cells. This targeted approach aims to achieve faster disease remission with potentially lower overall drug dosages.